Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke
Stroke
(
IF7.8
)
Pub Date : 2021-08-31, DOI: 10.1161/strokeaha.121.034705
Erik Lundström
,
Eva Isaksson
1,
2,
3
,
Nina Greilert Norin
4
,
Per Näsman
5
,
Per Wester
6,
7
,
Björn Mårtensson
8
,
Bo Norrving
9
,
Håkan Wallén
10
,
Jörgen Borg
11,
12
,
Graeme J Hankey
13,
14
,
Maree L Hackett
15,
16
,
Gillian E Mead
17
,
Martin S Dennis
17
,
Katharina S Sunnerhagen
18
Affiliation
Uppsala University, Sweden (E.I.).
Department of Clinical Neuroscience, Neurology (E.I.), Karolinska Institutet, Stockholm.
Department of Neurology, Danderyd Hospital, Stockholm, Sweden (E.I.).
Department of Clinical Sciences, Danderyd Hospital (N.G.N.), Karolinska Institutet, Stockholm.
Centre for Safety Research, KTH Royal Institute of Technology, Stockholm, Sweden (P.N.).
Department of Clinical Sciences (P.W.), Karolinska Institutet, Stockholm.
Department of Public Health & Clinical Medicine, Umeå University, Sweden (P.W.).
Department of Clinical Neurosciences (B.M.), Karolinska Institutet, Stockholm.
Department of Clinical Sciences, Neurology, Lund University, Sweden (B.N.).
Department of Clinical Sciences (H.W.), Karolinska Institutet, Stockholm.
Department of Neuroscience, NeurologyDepartment of Clinical Sciences (J.B.).
Department of Clinical Sciences (J.B.), Karolinska Institutet, Stockholm.
Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth (G.J.H.).
Department of Neurology, Sir Charles Gairdner Hospital, Perth, Western Australia (G.J.H.).
The George Institute for Global Health, Faculty of Medicine, University of New South Wales Sydney (M.L.H.).
The University of Central Lancashire, United Kingdom (M.L.H.).
University of Edinburgh, Royal Infirmary, Edinburgh, United Kingdom (G.E.M., M.S.D.).
Institute of Neuroscience and Physiology-Clinical Neuroscience, The Sahlgrenska Academy, University of Gothenburg, Sweden (K.S.S.).
京公网安备 11010802027423号